155 related articles for article (PubMed ID: 15777262)
1. Transglutaminases as targets for pharmacological inhibition.
Wodzinska JM
Mini Rev Med Chem; 2005 Mar; 5(3):279-92. PubMed ID: 15777262
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminases in disease.
Kim SY; Jeitner TM; Steinert PM
Neurochem Int; 2002 Jan; 40(1):85-103. PubMed ID: 11738475
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminases - possible drug targets in human diseases.
Gentile V; Cooper AJ
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):99-104. PubMed ID: 15078184
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Martin A; Romito G; Pepe I; De Vivo G; Merola MR; Limatola A; Gentile V
Curr Med Chem; 2006; 13(16):1895-902. PubMed ID: 16842200
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase inhibitors: a patent review.
Keillor JW; Apperley KY
Expert Opin Ther Pat; 2016; 26(1):49-63. PubMed ID: 26560530
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminases: nature's biological glues.
Griffin M; Casadio R; Bergamini CM
Biochem J; 2002 Dec; 368(Pt 2):377-96. PubMed ID: 12366374
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 inhibitors and their therapeutic role in disease states.
Siegel M; Khosla C
Pharmacol Ther; 2007 Aug; 115(2):232-45. PubMed ID: 17582505
[TBL] [Abstract][Full Text] [Related]
8. New target against inflammatory diseases: transglutaminase 2.
Kim SY
Arch Immunol Ther Exp (Warsz); 2004; 52(5):332-7. PubMed ID: 15507874
[TBL] [Abstract][Full Text] [Related]
9. The multifaceted role of transglutaminase in neurodegeneration: review article.
Karpuj M; Steinman L
Amino Acids; 2004 Jul; 26(4):373-9. PubMed ID: 15290343
[TBL] [Abstract][Full Text] [Related]
10. Reduced transglutaminase-catalyzed protein aggregation is observed in the presence of creatine using sedimentation velocity.
Burguera EF; Love BJ
Anal Biochem; 2006 Mar; 350(1):113-9. PubMed ID: 16445883
[TBL] [Abstract][Full Text] [Related]
11. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration.
Citron BA; Suo Z; SantaCruz K; Davies PJ; Qin F; Festoff BW
Neurochem Int; 2002 Jan; 40(1):69-78. PubMed ID: 11738473
[TBL] [Abstract][Full Text] [Related]
12. Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?
Cooper AJ; Jeitner TM; Gentile V; Blass JP
Neurochem Int; 2002 Jan; 40(1):53-67. PubMed ID: 11738472
[TBL] [Abstract][Full Text] [Related]
13. [Transglutaminase and neurodegenerative diseases].
Liu Z; Zeng J; Zeng S; Tang B; Wang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Aug; 32(4):562-6. PubMed ID: 26252108
[TBL] [Abstract][Full Text] [Related]
14. Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
De Vivo G; Di Lorenzo R; Ricotta M; Gentile V
Curr Med Chem; 2009; 16(36):4767-73. PubMed ID: 19929789
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition.
Hoffner G; André W; Vanhoutteghem A; Souès S; Djian P
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):217-31. PubMed ID: 19811443
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
Elli L; Bergamini CM; Bardella MT; Schuppan D
Dig Liver Dis; 2009 Aug; 41(8):541-50. PubMed ID: 19195940
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Martin A; De Vivo G; Ricotta M; Iannuzzi M; Gentile V
Recent Pat CNS Drug Discov; 2010 Nov; 5(3):195-202. PubMed ID: 20636272
[TBL] [Abstract][Full Text] [Related]
18. Assays for transglutaminases in cell death.
Melino G; Candi E; Steinert PM
Methods Enzymol; 2000; 322():433-72. PubMed ID: 10914039
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis.
Bakker EN; Pistea A; VanBavel E
J Vasc Res; 2008; 45(4):271-8. PubMed ID: 18212504
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A; Giuliano A; Collaro D; De Vivo G; Sedia C; Serretiello E; Gentile V
Amino Acids; 2013 Jan; 44(1):111-8. PubMed ID: 21938398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]